2023 annual financial data
Corvus Pharmaceuticals 2023 Operating margin
Corvus Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -23,407,000 USD and net income was -27,029,000 USD.
Operating cash flow was -23,935,000 USD.
Get free Corvus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -23,407,000 USD
- Net income
- -27,029,000 USD
- Operating cash flow
- -23,935,000 USD